AAAAAA
Results:
1-13
|
Results: 13
Authors:
Matthys, P
Hatse, S
Vermeire, K
Wuyts, A
Bridger, G
Henson, GW
De Clercq, E
Billiau, A
Schols, D
Citation: P. Matthys et al., AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice, J IMMUNOL, 167(8), 2001, pp. 4686-4692
Authors:
Proost, P
Schutyser, E
Menten, P
Struyf, S
Wuyts, A
Opdenakker, G
Detheux, M
Parmentier, M
Durinx, C
Lambeir, AM
Neyts, J
Liekens, S
Maudgal, PC
Billiau, A
Van Damme, J
Citation: P. Proost et al., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties, BLOOD, 98(13), 2001, pp. 3554-3561
Authors:
Struyf, S
Proost, P
Lenaerts, JP
Stoops, G
Wuyts, A
Van Damme, J
Citation: S. Struyf et al., Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1, BLOOD, 97(8), 2001, pp. 2197-2204
Authors:
Van Coillie, E
Van Aelst, I
Wuyts, A
Vercauteren, R
Devos, R
De Wolf-Peeters, C
Van Damme, J
Opdenakker, G
Citation: E. Van Coillie et al., Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle, AM J PATH, 159(4), 2001, pp. 1405-1414
Authors:
D'Haese, A
Wuyts, A
Dillen, C
Dubois, B
Billiau, A
Heremans, H
Van Damme, J
Arnold, B
Opdenakker, G
Citation: A. D'Haese et al., In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse, J INTERF CY, 20(7), 2000, pp. 667-674
Authors:
Schutyser, E
Struyf, S
Menten, P
Lenaerts, JP
Conings, R
Put, W
Wuyts, A
Proost, P
Van Damme, J
Citation: E. Schutyser et al., Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells, J IMMUNOL, 165(8), 2000, pp. 4470-4477
Authors:
Van den Steen, PE
Proost, P
Wuyts, A
Van Damme, J
Opdenakker, G
Citation: Pe. Van Den Steen et al., Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact, BLOOD, 96(8), 2000, pp. 2573-2581
Authors:
Van den Steen, PE
Proost, P
Wuyts, A
Van Damme, J
Opdenakker, G
Citation: Pe. Van Den Steen et al., Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact, BLOOD, 96(8), 2000, pp. 2673-2681
Authors:
Wuyts, A
Schutyser, E
Menten, P
Struyf, S
D'Haese, A
Bult, H
Opdenakker, G
Proost, P
Van Damme, J
Citation: A. Wuyts et al., Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages, BIOCHEM, 39(47), 2000, pp. 14549-14557
Authors:
Schols, D
Proost, P
Struyf, S
Wuyts, A
De Meester, I
Scharpe, S
Van Damme, J
De Clercq, E
Citation: D. Schols et al., CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity (vol 39, pg 175, 1998), ANTIVIR RES, 40(3), 1999, pp. 189-190
Authors:
Wuyts, A
D'Haese, A
Cremers, V
Menten, P
Lenaerts, JP
De Loof, A
Heremans, H
Proost, P
Van Damme, J
Citation: A. Wuyts et al., NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency, J IMMUNOL, 163(11), 1999, pp. 6155-6163
Authors:
Menten, P
Struyf, S
Schutyser, E
Wuyts, A
De Clercq, E
Schols, D
Proost, P
Van Damme, J
Citation: P. Menten et al., The LD78 beta isoform of MIP-1 alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine, J CLIN INV, 104(4), 1999, pp. R1-R5
Authors:
Wuyts, A
Govaerts, C
Struyf, S
Lenaerts, JP
Put, W
Conings, R
Proost, P
Van Damme, J
Citation: A. Wuyts et al., Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumorcells and leukocytes reveals NH2-terminal heterogeneity - Functional comparison of different natural isoforms, EUR J BIOCH, 260(2), 1999, pp. 421-429
Risultati:
1-13
|